Table 4.
Clinical characteristics of the participants in stage 2.
| Cohort (1) | Cohort (2) | |||
|---|---|---|---|---|
| Controls | DR | Controls | DR | |
| Samples (n) | 613 | 380 | 929 | 545 |
| Male/female (n) | 289/324 | 188/192 | 529/400 | 303/242 |
| Age (years) | 63.69 ± 10.34 | 60.19 ± 11.23 | 59.74 ± 8.79 | 57.73 ± 9.24 |
| Diabetes duration (years) | 10 (7, 14) | 10 (6, 15) | 10 (7, 13) | 11 (8, 16) |
| BMI (kg/m2) | 24.74 ± 3.43 | 25.36 ± 3.65 | 24.86 ± 3.56 | 24.85 ± 3.5 |
| SBP (mmHg) | 133.59 ± 16.44 | 136.08 ± 19.29 | 130.99 ± 16.17 | 135.25 ± 17.68 |
| DBP (mmHg) | 80.83 ± 9.2 | 81.33 ± 9.82 | 79.99 ± 9.16 | 80.41 ± 9.29 |
| HbA1c (%) | 8.05 ± 1.79 | 8.89 ± 2.34 | 8.44 ± 1.83 | 9.11 ± 2.1 |
| HbA1c (mmol/mol) | 64.49 ± 19.59 | 73.61 ± 25.56 | 68.72 ± 19.96 | 76.09 ± 22.97 |
| AERs (mg/24 h) | 10.85 (6.41, 25.17) | 17.26 (7.91, 71.16) | 10.44 (6.65, 24.32) | 17.25 (7.89, 84.24) |
| eGFRs | 121.41 (103.49, 143.88) | 123.98 (102.11, 148.34) | 124.84 (105.89, 149.06) | 130.66 (102.93, 154.61) |
Data are n, mean ± SD, or median (interquartile range).
AERs = albumin excretion rates; BMI = body mass index; DBP = diastolic blood pressure; DKD = diabetic kidney disease; DR = diabetic retinopathy; eGFR = estimated glomerular filtration rate; HbA1c = haemoglobin A1c; SBP = systolic blood pressure.